Trinity Biotech plc Company Profile (NASDAQ:TRIB)

Analyst Ratings

Consensus Ratings for Trinity Biotech plc (NASDAQ:TRIB) (?)
Ratings Breakdown: 1 Hold Rating(s), 3 Buy Rating(s)
Consensus Rating:Buy (Score: 2.75)
Consensus Price Target: $18.00 (45.16% upside)

Analysts' Ratings History for Trinity Biotech plc (NASDAQ:TRIB)
Show:
DateFirmActionRatingPrice TargetActions
4/21/2016Roth CapitalReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/5/2016StephensReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
10/23/2015Craig HallumDowngradeBuy -> Hold$24.00 -> $14.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
9/3/2015Raymond James Financial Inc.Initiated CoverageOutperform$20.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 7/25/2014 forward)

Earnings

Earnings History for Trinity Biotech plc (NASDAQ:TRIB)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallActions
7/26/2016        
7/21/2016Q2$0.06$0.09$24.30 million$26.30 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
4/19/2016Q1$0.08$0.06ViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
3/3/2016Q4$0.09$0.29$251.00 million$271.20 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
10/22/2015Q3$0.09$0.10$25.40 million$27.20 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
7/28/2015Q2$0.14$0.07ViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
4/30/2015Q115$0.17$0.17$25.93 million$25.20 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
3/3/2015Q414$0.18$0.18$27.30 million$26.70 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
10/23/2014Q114$0.20$0.19$27.30 million$27.20 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
7/29/2014Q413$0.20$0.18$27.00 million$26.00 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
4/29/2014$0.19$0.18ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
3/4/2014Q4$0.21$0.20ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
10/17/2013Q313$0.21$0.21$24.68 million$24.10 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
7/30/2013Q2 2013$0.20$0.21$22.03 million$21.30 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
3/5/2013Q4 2012$0.21$0.20$21.84 million$20.80 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Trinity Biotech plc (NASDAQ:TRIB)
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20161$0.08$0.08$0.08
Q2 20162$0.05$0.07$0.06
Q3 20162$0.06$0.07$0.07
Q4 20162$0.06$0.07$0.07
Q1 20171$0.04$0.04$0.04
Q2 20171$0.06$0.06$0.06
Q3 20171$0.08$0.08$0.08
Q4 20171$0.08$0.08$0.08
(Data provided by Zacks Investment Research)

Dividends

Dividend History for Trinity Biotech plc (NASDAQ:TRIB)
AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable DateShare
5/23/2014annual$0.223.72%6/6/20146/10/20147/1/2014Tweet This Announcement  Share This Announcement on StockTwits
(Data available from 1/1/2013 forward)

Insider Trades

Insider Trading History for Trinity Biotech plc (NASDAQ:TRIB)
No insider trades for this company have been tracked by MarketBeat.com

Headlines

Latest Headlines for Trinity Biotech plc (NASDAQ:TRIB)
DateHeadline
07/23/16 10:39 AMStock Soars, Rewards Investors Nicely Today: Trinity Biotech plc (NASDAQ:TRIB) - Engelwood Daily
07/23/16 10:39 AMTrinity Biotech plc (NASDAQ:TRIB): Sell-Side Ratings and Company Earnings Glance - Engelwood Daily
07/23/16 10:39 AMTrinity Biotech Plc (TRIB) Reports Q2 EPS of $0.09 - StreetInsider.com
07/22/16 03:26 PMTrinity Biotech Plc: Strong price momentum but will it sustain? -
07/22/16 11:32 AMTrinity Biotech Plc :TRIB-US: Earnings Analysis: Q2, 2016 By the Numbers : July 22, 2016 -
07/21/16 09:42 AMTrinity Biotech Plc (TRIB) Reports Q2 EPS of $0.09
07/21/16 07:36 AM8:36 am Trinity Biotech reoirts Q2 EPS ex items of $0.06 vs $0.07 Capital IQ Consensus Estimate; revs $26.3 mln vs $24.68 mln Capital IQ Consensus Estimate -
07/21/16 07:22 AMTrinity Biotech Announces Quarter 2 Financial Results - [GlobeNewswire] - DUBLIN, Ireland, July 21, 2016-- Trinity Biotech plc, a leading developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory markets, today announced results for the ...
07/21/16 06:07 AMQ2 2016 Trinity Biotech PLC Earnings Release - Time Not Supplied -
07/20/16 07:56 PMAre Analysts Bearish Trinity Biotech plc (ADR) (NASDAQ:TRIB) After Last Week? - Press Telegraph
07/20/16 07:56 PMSell-side Value Play with Decent Upside: Trinity Biotech plc (NASDAQ:TRIB) - TGP
07/19/16 07:05 PMNext Weeks Broker Price Targets For Trinity Biotech Plc (NASDAQ:TRIB) - Fiscal Standard
07/15/16 12:10 PMTrinity Biotech plc (NASDAQ:TRIB) Earnings Concentration and Analyst Target Watch - Engelwood Daily
07/15/16 12:10 PMNew Broker Ratings For Trinity Biotech Plc (NASDAQ:TRIB) - FTSE News
07/14/16 10:33 AMTrinity Biotech plc to Announce Second Quarter Fiscal Year 2016 Financial Results - Stockhouse
07/14/16 05:28 AMTrinity Biotech to Announce Q2 2016 Results - [at noodls] - 390d5b54-7648-4a0c-ae6c-93e6b9fd2981.pdf Press Release dated July 14, 2016 Contact: Trinity Biotech plc Lytham Partners LLC Kevin Tansley Joe Diaz, Joe Dorame & Robert Blum (353)-1-2769800 602-889-9700 ...
07/14/16 05:06 AMTrinity Biotech plc to Announce Second Quarter Fiscal Year 2016 Financial Results - [GlobeNewswire] - DUBLIN, Ireland, July 14, 2016-- Trinity Biotech plc, a leading developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory markets, will report financial results for ...
07/13/16 07:14 PMTrinity Biotech plc (NASDAQ:TRIB) Wall Street Analyst Recommendation Outlook - Telanagana Press
07/12/16 11:13 AMOption Market: Trinity Biotech plc Risk Hits An Inflection Point - CML News
07/12/16 11:13 AMHow Analysts Feel About Trinity Biotech plc (ADR) (NASDAQ:TRIB)? - Press Telegraph
07/11/16 08:22 AMStock Rating Watch and Earnings Insight for Trinity Biotech plc (NASDAQ:TRIB) - Press Telegraph
07/08/16 06:48 PMSyneron Medical Ltd. versus Trinity Biotech plc Head to Head Compare - CML News
07/08/16 06:48 PMCan Trinity Biotech plc (NASDAQ:TRIB) Improve on the Earnings Front? - Engelwood Daily
07/08/16 06:48 PMCompany Stock Focus for Trinity Biotech plc (NASDAQ:TRIB): Which Way Will Shares Head? - Press Telegraph
07/08/16 06:48 PMBroker Outlook For Trinity Biotech Plc (NASDAQ:TRIB) - Fiscal Standard
07/07/16 09:37 AMCutera, Inc. versus Trinity Biotech plc Head to Head Compare - CML News
07/07/16 09:37 AMTrinity Biotech plc (NASDAQ:TRIB) Stock Update: Check on Ratings and Target Price - Telanagana Press
07/02/16 06:21 PMLETTERS: Readers discuss Midway Pantherettes, veterans’ souls, local rainfall, police affairs and one brave boy
07/02/16 06:21 PMQuickly: Communities should charge for political signs
07/02/16 06:21 PMJury awards $27M to 4 fired Allstate employees
07/02/16 06:21 PMGun shop cancels raffle of AR-15 rifle for Orlando victims
07/02/16 06:21 PMMinor league report: Owen adapts nicely to pro baseball
07/02/16 06:21 PMUtah Jazz forward Trevor Booker to sign with Brooklyn Nets
07/02/16 09:27 AMShrimp slaves wait for justice 8 months after Thai raid - Casper Star-Tribune Online
07/02/16 09:27 AMIn Brexit, London startups see risk _ and some opportunities - Casper Star-Tribune Online
07/02/16 09:27 AMThe Latest: California Sierra fire forces evacuations - Casper Star-Tribune Online
07/02/16 09:27 AMAustralians vote in tight general election contest - Casper Star-Tribune Online
07/02/16 09:27 AMSweden backs sale of German coal mines to Czech group - Casper Star-Tribune Online
07/02/16 09:27 AMClinton's choice for first event with Obama: North Carolina - Casper Star-Tribune Online
07/02/16 09:27 AMFirst woman president: How great a milestone? Women differ - Casper Star-Tribune Online
07/02/16 09:27 AMThe Latest: Govt says Indian girl killed in Bangladesh siege - Casper Star-Tribune Online
07/02/16 09:27 AMScaife heirs seek Trib Total Media financial records - Pittsburgh Post-Gazette
07/01/16 06:53 PMQuickly: Sad farewell for members of St. Mark
07/01/16 06:53 PMTrib okays SABMiller takevover
07/01/16 06:53 PMNew in Trib+Water: Utilities and Water Conservation
07/01/16 06:53 PMJudge: Special prosecutor to investigate Chicago officers
07/01/16 06:53 PMOfficer involved in fatal shooting works for U.S. Marshals Service; trooper hurt while responding expected to recover
07/01/16 06:53 PMNews roundup: Sanders still itching for a convention fight
07/01/16 06:53 PMScaife heirs seek Trib Total Media financial records
06/29/16 09:36 AMTrinity Biotech plc Stock Momentum Hits Weakness - CML News

Social

About Trinity Biotech plc

Trinity Biotech plc logoTrinity Biotech plc (Trinity Biotech) develops, acquires, manufactures and markets medical diagnostic products for the clinical laboratory and point-of-care segments of the diagnostic market. These products are used to detect autoimmune, infectious and sexually transmitted diseases, diabetes and disorders of the liver and intestine. Trinity Biotech also is a provider of raw materials to the life sciences and research industries globally. Trinity Biotech markets its portfolio of almost 850 products to customers in approximately 100 countries around the world. The primary market for Trinity Biotech's diagnostic products is the Americas (which consists principally of North America and South America). Its products are classified as point-of-care, emergency medicine, clinical laboratory and blood bank screening. The Company markets products under Uni-Gold, Recombigen, Meritas, Captia, MicroTrak, Bartels, MarDx, MarBlot, Premier, Ultra2, ImmuBlot, ImmuGlo, ImmuLisa, OTOblot and EZ.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Diagnostic Substances
  • Sub-Industry: N/A
  • Exchange: NASDAQ
  • Symbol: TRIB
  • CUSIP:
Key Metrics:
  • Previous Close: $12.40
  • 50 Day Moving Average: $11.09
  • 200 Day Moving Average: $10.97
  • P/E Ratio: 52.77
  • P/E Growth: 3.37
  • Market Cap: $285.40M
  • Beta: 0.92
  • Current Year EPS Consensus Estimate: $0.21 EPS
  • Next Year EPS Consensus Estimate: $0.44 EPS
Additional Links:
Trinity Biotech plc (NASDAQ:TRIB) Chart for Monday, July, 25, 2016